Protective effect of silymarin on Cisplatin-induced nephrotoxicity in rats

Pakistan Journal of Nutrition

Volumn 9, Issue 7, 2010, Pages 624-636

  Abdelmeguid, Nabila E ^a   Chmaisse, Hania N ^b   Zeinab, Noura S Abou ^b  

^a Alexandria University Faculty Of Science   (Egypt)

^b BEIRUT ARAB UNIVERSITY   (Lebanon)

Author keywords

Cisplatin; Histopathology; Kidney; Silymarin; Ultrastructure

Indexed keywords

CISPLATIN; SILYMARIN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BODY WEIGHT; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG INDUCED DISEASE; HISTOLOGY; KIDNEY CELL; KIDNEY MASS; KIDNEY STRUCTURE; MALE; NEPHROTOXICITY; NONHUMAN; RAT; RENAL PROTECTION; WEIGHT REDUCTION;

ANIMALIA; RATTUS;

EID: 78649623963     PISSN: 16805194     EISSN: None     Source Type: Journal    
DOI: 10.3923/pjn.2010.624.636     Document Type: Article

References (40)

1. Ajith, T.A., N. Jose and K.K. Janardhanan, 2002. Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus. J. Exp. Clin. Cancer Res., 21: 213-217.
2. Arany, I. and R.L. Safirstein, 2003. Cisplatin nephrotoxicity. Semin. Nephrol., 23: 460-464.
3. Behling, E.B., C.S. Milena, D.C.F. Heloísa, M.G.A. Lusânia, S.C. Roberto and P.B. Maria de Lourdes, 2006. Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys. Pharmacol. Rep., 58: 526-532.
4. Borsari, M., C. Gabbi, F. Ghelfi, R. Grandi, M. Saladini, S. Severi and F. Borella, 2001. Silybin, a new iron-chelating agent. J. Inorg. Biochem., 85: 123-129.
5. Chirino, Y.I., R. Hernández-Pando and J. Pedraza-Chaverí, 2004. Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC Pharmacol., 4: 20-29.
6. Daugaard, G., U. Abilgaard, N.H. Holstein-Rathlou, I. Bruunshuus, D. Bucher and P.P. Leyssac, 1988a. Renal tubular function in patients treated with highdose cisplatin. Clm. Pharmacol. Ther, 44: 164-172.
7. Daugaard, G., N.H. Holstein-Rathloum and P.P. Leyssac, 1988b. Effect of cisplatin on proximal convuluted and straight segments of the rat kidney. J. Pharmacol. Exp. Ther., 244: 1081-1085.
8. El-Abd, S. and Y. Okda, 2007. Ameliorative role of silymarin against ribavarin induced toxicity in the kidney of albino rat. Egypt. J. Exp. Biol. (Zool.)., 3: 127-133.
9. Eminzade, S., F.V. Uras and F. Izzettin, 2008. Silymarin protects liver against toxic effects of antituberculosis drugs in experimental animals. Nutr. Metab., 5: 18.
10. Erkut, M.A., I. Aydogdu, I. Kuku, E. Kaya and O. Ozhan, 2008. Anticancer drug induced glomerular dysfunction. World J. Med. Sci., 3: 5-9.
11. Gaedeke, J., L.M. Fels, C. Bokemeyer, U. Mengs, H. Stolte1 and H. Lentzen, 1996. Cisplatin nephrotoxicity and protection by silibinin. Nephrol. Dial. Transplant, 11: 55-62.
12. Hannemann, J. and K. Baumann, 1998. Ciplatininduced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: Different effects of antioxidants and radical scavengers. Toxicology., 51: 119-132.
13. Hogan, F.S., N.K. Krishnegowda, M. Mikhailova and M.S. Kahlenberg, 2007. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer. J. Surg. Res., 143: 58-65.
14. Ikarashi, Y., T. Kakýhara, C. Imai, A. Tanaka, A. Watanabe and M. Uchýyama, 2004. Glomerular dysfunction, independent of tubular dysfunction, induced by antineoplastic chemotherapy in children. Pediatrics Int., 46: 570-575.
15. Kakihara, T., C. Imai, H. Hotta, Y. Ikarashi, A. Tanaka and M. Uchiyama, 2003. Impaired Tubular Excretory Function as a Late Renal Side Effect of. Chemotherapy in Children. J. Pediatr. Hematol. Oncol., 25: 209-214.
16. Karimi, G., M. Ramezani and Z. Tahoonian, 2005. Cisplatin nephrotoxicity and protection by milk thistle extract in rats. Evid. Based Complement Alternat. Med., 2: 383-386.
17. Kintzel, P.E., 2001. Anticancer drug-induced kidney disorders. Incidence, prevention and management. Drug Safety., 24: 19-38.
18. Kohn, S., M. Fradis, J. Ben-David, J. Zidan and E. Robinson, 2002. Nephrotoxicity of combined treatment with cisplatin and gentamicin in the guinea pig: Glomerular injury findings. Ultrastructural Pathol., 26: 371-382.
19. Kuhlmann, M.K., E. Horsch, G. Burkhardt, M. Wagner and H. Köhler, 1998. Reduction of cisplatin toxicity in cultured renal tubular cells by the bioflavonoid quercetin. Arch. Toxicol., 72: 536-540.
20. Laekeman, G., S. De Coster and K. De Meyer, 2003. St. Mary's Thistle: An overview. J. Pharm. Belg., 58: 28-31. Review. French.
21. LAzou, B., I. Dubus, C. Ohayon-Courtès and J. Cambar, 2002. Human glomerular mesangial IP15 cell line as a suitable model for in vitro cadmium cytotoxicity studies. Cell Biol. Toxicol., 23: 267-278.
22. Lee, C.K., K.K. Park, S.S. Lim, J.H.Y. Park and W.Y. Chung, 2007. Effects of the licorice extract against tumor growth and cisplatin-induced toxicity in a mouse xenograft model of colon cancer. Biol. Pharm. Bull., 30: 2191-2195.
23. Loh, A.H.L. and A.H. Cohen, 2009. Drug-induced kidney disease-pathology and current concepts. Ann. Acad. Med. Singapore, 38: 240-250.
24. Mansour, H.H., F.H. Hafez and N.M. Fahmy, 2006. Silymarin modulates cisplatin-induced oxidative stress and hepatotoxicity in rats. J. Biochem. Mol. Biol., 39: 656-661.
25. Matsushima, H., K. Yonemura, K. Ohishi and A. Hishida, 1998. The role of oxygen free radicals in cisplatininduced acute renal failure in rats. J. Lab. Clin. Med., 131: 518-526.
26. Montine, T.J. and R.F. Borch, 1990. Role of endogenous sulfur-containing nucleophiles in an in vitro model of cis-diamminedichloroplatinum(II)-induced nephrotoxicity. Biochem. Pharmacol., 39: 1751-1777.
27. Mora Lde, O., L.M. Antunes, H.D. Francescato and L. Bianchi Mde, 2003. The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol. Res., 47: 517-522.
28. Morales, A.L., C. Vicente-Sanchez, Santiago Sandoval, J. Egido and P. Mayoral, 2006. Protective effect of quercetin on experimental chronic cadmium nephrotoxicity in rats is based on its antioxidant properties. Food Chem. Toxicol., 44: 2092-2100.
29. Morigi, M., K. Imberti, C. Zoja, D. Corna and S. Tomasoni, 2004. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J. Am. Soc. Nephrol., 15: 1794-1804.
30. Pal, S., A. Sengupta Sadhu, S. Patra and K.K. Mukherjea, 2008. Histological vis-a-vis biochemical assessment on the toxic level and antineoplastic efficacy of a synthetic drug Pt-ATP on experimental animal models. J. Exp. Clin. Cancer Res., 27: 68.
31. Park, H.R., E.J. Ju, S.K. Jo, U. Jung, S.U. Kim and S.T. Yee, 2009. Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice. BMC Cancer, 9: 85.
32. Pratibha, R., R. Sameer, P.V. Rataboli, D.A. Bhiwgade and C.Y. Dhume, 2006. Enzymatic studies of cisplatin induced oxidative stress in hepatic tissue of rats. Eur. J. Pharmacol., 532: 290-293.
33. Rao, M. and M.M. Rao, 1992. Protective effects of selenomethionine against cisplatin-induced renal toxicity in mice and rats. J. Pharm. Pharmacol., 50: 687-691.
34. Rodriguez-Barbero, A., B. LAzou, J. Cambar and J.M. Lopez-Novoa, 2000. Potential use of isolated glomeruli and cultured mesangial cells as in vitro models to assess nephrotoxicity. Cell Biol. Toxicol., 16: 145-53. Invited Review.
35. Saad, S.Y., T.O. Najjar and M. Alashari, 2004. Role of non-selective adenosine receptor blockade and phosphodiesterase inhibition in cisplatin-induced nephrogonadal toxicity in rats. Clin. Exp. Pharmacol. Physiol., 31: 862-867.
36. Sadzuka, Y., T. Shoij and A. Takino, 1992. Effects of cisplatin on the activity of enzymes which protect against lipid peroxidation. Biochem. Pharmacol., 43: 1872-1875.
37. Shalaby, T., A.M. Ghanem and H.S. Ramadan, 2006. Cytotoxicity changes of cisplatin drug in the presence of magnetic fields. Romanian J. Biophys., 4: 229-241.
38. Shimeda, Y., Y. Hirotani, Y. Akimoto, K. Shindou, Y. Yoshio Ijiri, T. Nishihorl and K. Tanaka, 2005. Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biol. Pharm. Bull., 28: 1635-1638.
39. Stewart, D.J., R.S. Benjamin, M. Luna, L. Feun, R. Caprioli, W. Seifert and T.L. Loo, 1982. Human tissue distribution of platinum after cisdiamminedichloroplatinum. Cancer Chemother. Pharmacol., 10: 51-54.
40. Yilmaz, H.R., M. Iraz, S. Sogut, H. Ozyurt, Z. Yildirim, O. Akyol and S. Gergerlioglu, 2004. The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats. Pharmacol. Res., 50: 287-290.